Home › Free Stock Grades › CDNA
CareDx, Inc (CDNA) Stock Grade
CDNA · Healthcare
B-
Market Cap
$3.3B
P/E Ratio
29.2
Revenue Growth (YoY)
+13.8%
Net Margin
-5.6%
Return on Equity
—
Dividend Yield
None
About CareDx, Inc's fundamentals
CareDx is a healthcare diagnostics company with a market capitalization of $3.3 billion that has demonstrated revenue growth of 13.8% year-over-year, indicating expanding demand for its diagnostic services. However, the company is currently unprofitable, with a net margin of -5.6% and a reported net loss in its latest annual statement, reflecting the costs associated with scaling its operations. Despite these accounting losses, CareDx generates positive free cash flow, suggesting the business converts revenue into actual cash at an operational level. The company trades at a P/E ratio of 29.2 and does not pay a dividend.